Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)
- Sunday, September 29, 2019, 7:07
- Finance
- Add a comment
IRVINE, Calif. and AMSTERDAM, Sept. 29, 2019 /PRNewswire/ — Agendia Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at the European Society for Medical Oncology (ESMO) Congress 2019, taking place from September 27…
About the Author
adminasapcorp has written 39584 stories on this site.